| Literature DB >> 29507897 |
Abstract
Entities:
Year: 2018 PMID: 29507897 PMCID: PMC5831025 DOI: 10.1002/hep4.1169
Source DB: PubMed Journal: Hepatol Commun ISSN: 2471-254X
Figure 1Metabolic pathway of vinyl chloride and the impact on toxicity. Vinyl chloride is primarily metabolized to chloroethylene oxide by hepatic CYP2E1. The active metabolite undergoes rearrangement to chloroacetaldehyde or is metabolized to glycolaldehyde by epoxide hydrolase. Chloroacetaldehyde can be further converted to 2‐chloroethanol or metabolized to 2‐chloroacetic acid by aldehyde dehydrogenase. Glycolaldehyde as well as glutathione conjugates of chloroethylene oxide, chloroacetaldehyde, 2‐chloroethanol, and 2‐chloroacetic acid are inactive metabolites. Chloroethylene oxide and chloroacetaldehyde are the reactive intermediate metabolites, and their formation of DNA and protein adducts is closely related to the carcinogenic property of vinyl chloride. In addition to vinyl chloride, 2‐chloroethanol is involved in the enhanced susceptibility to liver injury by dysregulating glucose metabolism and inducing mitochondrial damage. Diet‐induced obesity or a high‐fat diet can sensitize the liver for injury induced by sub‐ppm levels of vinyl chloride. Alcohol and a high‐fat diet also enhance susceptibility to liver injury by inducing CYP2E1. Abbreviation: ER, endoplasmic reticulum.